Harvard Bioscience
HBIO
HBIO
80 hedge funds and large institutions have $143M invested in Harvard Bioscience in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
+8
Holders Change %
+11.11%
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
29
Reduced
26
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$15.7M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
$31.8M |
| 3 |
State Street
Boston,
Massachusetts
|
$2.55M |
| 4 |
Northern Trust
Chicago,
Illinois
|
$2.09M |
| 5 |
RA
Royce & Associates
New York
|
$8.37M |
